WallStreetZenWallStreetZen

NYSE: ZBH
Zimmer Biomet Holdings Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Zimmer Biomet Holdings earnings were $903.8M for the trailing 12 months ending Dec 31, 2024, with -9.4% growth year over year. The latest ZBH earnings report on Dec 31, 2024 announced Q4 2024 earnings of $239.5M, down 3.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ZBH reported annual earnings of $903.8M, with -11.7% growth. The next ZBH earnings date is Apr 30, 2025.

ZBH past earnings growth

How has ZBH's earnings growth performed historically?

Company
-9.37%
Industry
48.25%
Market
63.03%
ZBH's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ZBH's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ZBH's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ZBH earnings history

Current Revenue
$7.7B
Current Earnings
$903.8M
Current Profit Margin
11.8%
ZBH's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

ZBH Return on Equity

Current Company
7.2%
Current Industry
11.5%
Current Market
34.1%
ZBH's Return on Equity (7.2%)... subscribe to Premium to read more.
High Return on Equity Performance

ZBH undefined

Current Company
4.2%
Current Industry
8%
ZBH is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ZBH announces earnings.

ZBH undefined

Current Company
6.63%
Current Industry
9%
ZBH has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ZBH vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ZBH$2.25B$903.80M-4.22%$4.45
PODD$423.70M$418.30M+99.27%$5.97
STE$1.24B$467.59M+0.43%$4.74
PHG$2.15B-$738.95MN/A-$0.79
ALGN$792.43M$421.36M+0.21%$5.63
View Top Medical Device Stocks

ZBH earnings dates

Next earnings date
Apr 30, 2025

Zimmer Biomet Holdings Earnings Reports & History FAQ

What were Zimmer Biomet Holdings's earnings last quarter?

On ZBH's earnings call on Invalid Date, Zimmer Biomet Holdings (NYSE: ZBH) reported Q4 2024 earnings per share (EPS) of $1.20, up 40.59% year over year. Total ZBH earnings for the quarter were $239.50 million. In the same quarter last year, Zimmer Biomet Holdings's earnings per share (EPS) was $2.02.

If you're new to stock investing, here's how to buy Zimmer Biomet Holdings stock.

When does Zimmer Biomet Holdings report earnings?

The next ZBH earnings date is Invalid Date. Add ZBH to your watchlist to be reminded of Zimmer Biomet Holdings's next earnings date.

What was ZBH's earnings growth in the past year?

As of Zimmer Biomet Holdings's earnings date in Invalid Date, Zimmer Biomet Holdings's earnings has grown -9.37% year over year. This is 57.62 percentage points lower than the US Medical Devices industry earnings growth rate of 48.25%. ZBH earnings in the past year totalled $903.80 million.

Is Zimmer Biomet Holdings profitable or losing money?

As of the last Zimmer Biomet Holdings earnings report, Zimmer Biomet Holdings is currently profitable. Zimmer Biomet Holdings's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $903.80 million, a 11.74% decrease year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.